Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $20,543 | 12 | 45.6% |
| Travel and Lodging | $11,428 | 29 | 25.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11,215 | 6 | 24.9% |
| Food and Beverage | $1,288 | 23 | 2.9% |
| Honoraria | $500.00 | 1 | 1.1% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $88.32 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| VENTANA MEDICAL SYSTEMS, INC. | $12,144 | 21 | $0 (2019) |
| Roche Diagnostics Corporation | $8,821 | 5 | $0 (2022) |
| Amgen Inc. | $4,595 | 10 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $4,551 | 6 | $0 (2023) |
| Genentech USA, Inc. | $3,786 | 6 | $0 (2018) |
| AstraZeneca UK Limited | $2,723 | 1 | $0 (2024) |
| Bristol Myers Squibb Company | $2,645 | 4 | $0 (2023) |
| GENZYME CORPORATION | $2,017 | 2 | $0 (2023) |
| Merck Sharp & Dohme LLC | $1,908 | 1 | $0 (2022) |
| Agilent Technologies, Inc. | $1,145 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,747 | 2 | AstraZeneca UK Limited ($2,723) |
| 2023 | $13,258 | 15 | E.R. Squibb & Sons, L.L.C. ($4,551) |
| 2022 | $6,613 | 6 | Roche Diagnostics Corporation ($3,560) |
| 2019 | $1,500 | 1 | VENTANA MEDICAL SYSTEMS, INC. ($1,500) |
| 2018 | $20,945 | 49 | VENTANA MEDICAL SYSTEMS, INC. ($10,644) |
All Payment Transactions
73 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $24.37 | General |
| 03/29/2024 | AstraZeneca UK Limited | LYNPARZA (Drug) | Consulting Fee | Cash or cash equivalent | $2,722.50 | General |
| Category: Oncology | ||||||
| 12/28/2023 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $550.00 | General |
| 12/14/2023 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $204.18 | General |
| 12/14/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $60.40 | General |
| 11/15/2023 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $1,868.00 | General |
| 11/15/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $149.22 | General |
| 10/13/2023 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $2,796.00 | General |
| 10/13/2023 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $699.00 | General |
| 08/25/2023 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $3,180.00 | General |
| 08/25/2023 | Bristol Myers Squibb Company | — | Consulting Fee | Cash or cash equivalent | $1,060.00 | General |
| 08/25/2023 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $1,060.00 | General |
| 06/30/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $29.89 | General |
| Category: Oncology | ||||||
| 06/30/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $16.88 | General |
| Category: Oncology | ||||||
| 06/29/2023 | Bristol Myers Squibb Company | — | Travel and Lodging | Cash or cash equivalent | $800.12 | General |
| 06/29/2023 | Bristol Myers Squibb Company | — | Travel and Lodging | Cash or cash equivalent | $602.20 | General |
| 06/28/2023 | Bristol Myers Squibb Company | — | Travel and Lodging | Cash or cash equivalent | $182.25 | General |
| 11/01/2022 | Agilent Technologies, Inc. | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| 11/01/2022 | Agilent Technologies, Inc. | — | Honoraria | Cash or cash equivalent | $500.00 | General |
| 11/01/2022 | Agilent Technologies, Inc. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 11/01/2022 | Agilent Technologies, Inc. | — | Travel and Lodging | In-kind items and services | $20.00 | General |
| 09/28/2022 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $1,907.50 | General |
| 08/09/2022 | Roche Diagnostics Corporation | BenchMark ULTRA (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,560.00 | General |
| Category: Tissue Diagnostics | ||||||
| 12/03/2019 | VENTANA MEDICAL SYSTEMS, INC. | BENCHMARK IHC/ISH PLATFORMS & REAGENTS (Device) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Tissue Diagnostics | ||||||
| 12/27/2018 | Roche Diagnostics International Ltd | RDI Research (Device) | Travel and Lodging | In-kind items and services | $227.74 | General |
| Category: Point of Care | ||||||
About Dr. Eric Konnick, MD
Dr. Eric Konnick, MD is a Anatomic Pathology & Clinical Pathology healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2010. The National Provider Identifier (NPI) number assigned to this provider is 1609190446.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Konnick, MD has received a total of $45,062 in payments from pharmaceutical and medical device companies, with $2,747 received in 2024. These payments were reported across 73 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($20,543).
Practice Information
- Specialty Anatomic Pathology & Clinical Pathology
- Other Specialties Molecular Genetic Pathology, Clinical Pathology/Laboratory Medicine
- Location Seattle, WA
- Active Since 03/23/2010
- Last Updated 07/10/2015
- Taxonomy Code 207ZP0102X
- Entity Type Individual
- NPI Number 1609190446
Products in Payments
- BENCHMARK IHC/ISH PLATFORMS & REAGENTS (Device) $9,669
- TD VENTANA Primary Staining Instruments and Reagents (Device) $5,034
- Non-Covered Product (Drug) $3,786
- BenchMark ULTRA (Device) $3,560
- LYNPARZA (Drug) $2,723
- VENTANA RESEARCH & DEVELOPMENT (Device) $2,474
- RDI Research (Device) $227.74
- OPDIVO (Biological) $46.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology & Clinical Pathology Doctors in Seattle
Meng-Che Yeh, Md, MD
Anatomic Pathology & Clinical Pathology — Payments: $428,161
Charles Alpers
Anatomic Pathology & Clinical Pathology — Payments: $114,121
Dr. Ryan Metcalf, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $37,636
Howard Shulman
Anatomic Pathology & Clinical Pathology — Payments: $22,639
Erin Rudzinski, Md, MD
Anatomic Pathology & Clinical Pathology — Payments: $16,144
Jing Zhang
Anatomic Pathology & Clinical Pathology — Payments: $10,240